Skip to main content

COVID-19: SMEs in Kenya set to benefit from KSH. 63.9M Relief Fund as Boehringer Ingelheim steps up effort with Global Support Program

COVID-19: SMEs in Kenya set to benefit from KSH. 63.9M Relief Fund as Boehringer Ingelheim steps up effort with Global Support Program

A Boehringer Ingelheim scientist from one of the areas of research and development (R&D)
Boehringer Ingelheim, one of the largest pharmaceuticals in the world has significantly stepped up its support to the fight against COVID-19. A Global Support Program has been set up to bring more financial relief, protective materials and medicine donations to healthcare institutions and communities in need around the world.

Local social enterprises are expected to receive EUR 555,000 an equivalent of KSH. 63.9M in support of their programmes in Kenya. Some of the beneficiaries of this fund include local enterprises such as Access Afya, Healthy Entrepreneurs and Jacaranda Health.

“As a pharmaceuticals company, we feel a strong commitment to offering our help to patients, and to those who help them”, said Hubertus von Baumbach, Chairman of the Board of Managing Directors. 

“Many of our employees want to participate in the program: we offer support through donations and paid-leave volunteering, engage in significant scientific projects and bring relief to communities in developing regions in Kenya and India, with whom we have a decade-long relationship. All this, plus the drive that I see with colleagues to ensure the continued production of medicines, is dedicated to the many, many people who suffer from COVID-19. Our thoughts are with them and their loved ones.”

A EUR 580,000 relief fund has been launched to support the global Making More Health (MMH) network of social entrepreneurs in Kenya and India, as well as the communities in which they live and work. The fund will help social enterprises and their activities to sustain a longer period of low economic activity and will invest in social entrepreneurial ideas that can help reduce the risk of Coronavirus spreading.

“Especially in times like these Social Entrepreneurs around the world are well placed to leverage their proximity to those in needs”, said Jean Scheftsik de Szolnok, member of the Board of Managing Directors and one of the founders of the MMH movement. “MMH communities such as self-help groups in India or people suffering from albinism in Kenya, have started to produce soap and at the same time education programs on hygiene awareness in their neighbourhoods.” Over the past years, more than 750 students at the MMH school and some 1,000 families in farmer cooperatives have been trained in hygiene and soap production in Kenya and India.

Boehringer Ingelheim is committed to the global community and to the well-being of people and animals. As a research-driven company, it started its support activities in January and will continue to do what it can to deliver a meaningful contribution in the fight against COVID-19. The company continues to support healthcare systems by reliably supplying drugs and through our research.

Boehringer Ingelheim initially started a EUR 1 million donations program in January for affected regions in China. With the Coronavirus spreading to become a global pandemic, efforts to provide relief and scientific support grew strongly these past few weeks. This ultimately resulted in a Global Support Program with four focus areas: Donations, Research for COVID-19 Therapies, Volunteering and Making More Health Relief Fund.

Boehringer Ingelheim has made available EUR 5.8 million for financial and in-kind donations for local emergency aid across its markets. This includes protective masks, disinfectants, inhalers and medicines. The company is also working with local organizations that use financial and medicine donations to organize help for patients in their communities.

Since January, a growing team of more than 100 highly engaged Boehringer Ingelheim scientists from all areas of research and development (R&D) have contributed to projects aimed at finding potential treatment solutions for COVID-19. “All of us are thinking about how we can find new ways to tackle this virus. This has led to a broad program pursuing many approaches in parallel”, says Dr Cyrille Kuhn, Executive Director Research, who leads Boehringer Ingelheim’s COVID-19 efforts since January. 

Moreover, an increasing number of collaboration partners and service providers is bolstering the team’s efforts. Most of the projects are part of larger collaborative efforts with academia, biotech and other pharma companies. Among them is a call by the Innovative Medicines Initiative of the EU (IMI), to which Boehringer Ingelheim is planning to commit in excess of 11,000 work hours in R&D. The company also joined the Bill & Melinda Gates Foundation COVID-19 Therapeutic Accelerator.

The company also joined the Bill & Melinda Gates Foundation COVID-19 Therapeutic Accelerator. In addition, Boehringer Ingelheim supports scientists worldwide with its open innovation portal opnMe.com, which offers 6 anti-viral compounds out of 43 high-quality pharmacological tool compounds at no cost for testing of research hypotheses.

Comments

Post a Comment

Popular posts from this blog

British Airways launches new reward app for executive club members

British Airways has launched a brand new app for members of its Executive Club. Members can use the app to discover new ways to collect and spend Avios, find new offers and see personalised ways to spend Avios based on the member’s Avios balance. The Executive Club Reward app will complement the current British Airways app, which is designed to help all British Airways customers book and service pre- and post-travel needs. The app has a simple, intuitive design, to help members navigate its different features. These features include the ability to access and make purchases through the British Airways Avios eStore – an important way many members collect Avios. Customers can also see different ways they can spend their Avios including a helpful tool which says how many more Avios are needed until a member can book reward flights to different destinations. As well as this, customers can see the latest Avios deals, view their last five transactions, and buy Avios, view accou...
Post a Comment
Read more

Narok School benefits from a Dormitory Courtesy of Procter and Gamble

STUDENTS OF OLOIGERO PRIMARY SCHOOL POSE FOR A PHOTO WITH THE P&G TEAM AND PARTNERS OUTSIDE THE NEWLY BUILT DOMITORY Pupils of Oloigero Primary School in Narok County have a reason to smile after Procter and Gamble funded the construction of a girl’s dormitory in the school. The facility, which will accommodate 80 girls, will help support and improve the access to quality education in the area. “Access to quality education is affected by a myriad of challenges in this country. Inadequate infrastructure is one of them.  The situation is even more dire for our girls thus the reason we are here today to commission this dormitory. We believe that this facility will be a critical resource to help keep our girls in school and together with other partners we will work to ensure that we change the narrative about girls missing school due to menstruation,” said Anthony Ng’ang’a,  Associate Brand Director -Commercial Leader - East Africa at Procter & Gamble (P&G)...
Post a Comment
Read more

Column: Caleb Otieno: Make empathy a reflex

‘Empathy is about standing in someone else 's shoes, feeling with his or her heart, seeing with his or her eyes. Reflection is the means of processing thoughts and feelings about an activity, incident, or day. It gives us a chance to come to terms with our thoughts and feelings surrounding it”  People who understand how to watch, listen and observe the actions and emotions of those around them are often perceived as the most successful in life. A conscious alignment of one’s self with others starts with the development of empathy in the early years.  In the early years of life from age two to seven, young children are naturally ego-centric and are very much inclined to think mostly about themselves and their immediate needs. They are not yet ready to consider the needs and feelings of others. Developing a sense of empathy is an important developmental process for young children. It is at the heart of good relationships, and it begins with valuing others and their perspectives....
Post a Comment
Read more